Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,965,916
-$56,165 QoQ
Shares Held
208,696
-16.0% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 263 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. NVAX ranks #62 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,965,916 | 208,696 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,022,081 | 248,413 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,214,145 | 329,486 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,241,073 | 258,486 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,600,288 | 254,014 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,780,153 | 277,715 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,880,064 | 358,217 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,741,857 | 375,444 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,315,299 | 261,872 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,043,110 | 1,682,659 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,736,832 | 1,611,840 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,185,482 | 992,470 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,262,702 | 1,112,073 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,229,909 | 1,043,277 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,022,026 | 488,524 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,975,207 | 218,418 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,835,294 | 94,017 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,395,672 | 73,261 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,529,596 | 31,660 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,666,835 | 12,864 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,640,924 | 12,439 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,981,824 | 16,446 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $832,422 | 7,465 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,252,379 | 20,788 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,746,849 | 20,958 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||